Autophagy-IN-13
Based on 1 Customer Validation
Autophagy-IN-13 is an autophagy inhibitor targeting ATG5. Autophagy-IN-13 blocks and disrupts protein-protein interactions between ATG5 and ATG16L1, and between ATG5 and TECAIR.Autophagy-IN-13 inhibits autophagy in living cells via reduced autophagosome formation and downregulated ATG8-PE conjugation. Autophagy-IN-13 can be used to study autophagy mechanisms.
For research use only. We do not sell to patients.
- Purity : 97.23%
- CAS No.: 2841473-81-0
- Formula: C24H18N2O6
- Molecular Weight:430.41
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
Autophagy-IN-13 (2.5-40 μM; 16 h) dose-dependently inhibits autophagy in COS-7 cells[1].
Autophagy-IN-13 (1.25-40 μM; 6 h) dose-dependently reduces LC3-II levels, indicating autophagy inhibition, in COS-7, U-937, and THP-1 cells[1].
Autophagy-IN-13 blocks the ATG5-ATG16L1 and ATG5-TECAIR protein-protein interactions in vitro with IC50 values of 1.1 μM and 1.7 μM, respectively[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:COS-7
-
Concentration:2.5; 5; 10; 20; 40 μM
-
Incubation Time:16 h
-
Result:Caused a dose-dependent left shift in LC3 fluorescence intensity, indicating autophagy inhibition.
-
Cell Line:COS-7, U-937, THP-1
-
Concentration:1.25; 2.5; 5; 10; 20 μM (COS-7 cells); 5; 10; 20; 40 μM (U-937 and THP-1 cells)
-
Incubation Time:6 h
-
Result:Reduced the LC3-II/β-actin ratio from 1.01 at 1.25 μM to 0.64 at 20 μM in COS-7 cells.
Caused a significant dose-dependent decrease in LC3-II protein levels in U-937 and THP-1 cells.
Chemical Information
-
CAS No. 2841473-81-0
-
Appearance Solid
-
Molecular Weight 430.41
-
Formula C24H18N2O6
-
Color Brown to reddish brown
-
SMILES
OC(CCN1C(C2=CC=CC=C2)=C/C(C1=O)=C\C3=CC=C(C4=CC=C(C=C4)[N+]([O-])=O)O3)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
-
Data Sheet (283 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Xiang H, et al. Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5. J Med Chem. 2023 Feb 23;66(4):2457-2476. [Content Brief]
[2]. Xiang H, et al. Discovery of small-molecule inhibitors for the protein-protein interactions involving ATG5. Autophagy Rep. 2023;2(1):2215617. Published 2023 May 27. [Content Brief]
[3]. Yan D, et al. Molecular dynamics-driven drug discovery. Phys Chem Chem Phys. 2025;27(24):12633-12651. Published 2025 Jun 18. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)